What does the new research on Vitamin B12-based therapy for brain cancer reveal?
The experiment found that a modified analogue of vitamin B12 known as nitrosylcobalamin (NO-Cbl) that was specifically designed to include nitric oxide, a substance that can kill tumour cells selectively, managed to pass the blood-brain barrier. While the research looks promising, there is still a long way to go before it can be applied to patients
· 8/5/2026, 9:43:27 AM· 2 min read
The experiment found that a modified analogue of vitamin B12 known as nitrosylcobalamin (NO-Cbl) that was specifically designed to include nitric oxide, a substance that can kill tumour cells selectively, managed to pass the blood-brain barrier. While the research looks promising, there is still a long way to go before it can be applied to patients
Read original story →Related stories
health
Leqembi for early Alzheimer's treatment launched in India after CDSCO nod
health
A single US measles outbreak can cost millions of dollars, study estimates
health
Ebola kills 1,700 in eastern Congo as fastest-growing outbreak surges
health